Acknowledgement
Supported by a Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Science, Information and Communication Technology, and Future Planning (NRF-2017R1A2B4009661) and faculty research grant of Yonsei University College of Medicine (6-2016-0077).
References
- Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003;349:583-596 https://doi.org/10.1056/NEJMra023144
- Banypersad SM, Moon JC, Whelan C, Hawkins PN, Wechalekar AD. Updates in cardiac amyloidosis: a review. J Am Heart Assoc 2012;1:e000364
- Banypersad SM, Sado DM, Flett AS, Gibbs SD, Pinney JH, Maestrini V, et al. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 2013;6:34-39 https://doi.org/10.1161/CIRCIMAGING.112.978627
- Fontana M, Chung R, Hawkins PN, Moon JC. Cardiovascular magnetic resonance for amyloidosis. Heart Fail Rev 2015;20:133-144 https://doi.org/10.1007/s10741-014-9470-7
- Di Bella G, Minutoli F, Mazzeo A, Vita G, Oreto G, Carerj S, et al. MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy. AJR Am J Roentgenol 2010;195:W394-W399 https://doi.org/10.2214/AJR.09.3721
- Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM, et al. Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2015;132:1570-1579 https://doi.org/10.1161/CIRCULATIONAHA.115.016567
- Baroni M, Nava S, Quattrocchi G, Milazzo A, Giannattasio C, Roghi A, et al. Role of cardiovascular magnetic resonance in suspected cardiac amyloidosis: late gadolinium enhancement pattern as mortality predictor. Neth Heart J 2018;26:34-40 https://doi.org/10.1007/s12471-017-1046-4
- Banypersad SM. The evolving role of cardiovascular magnetic resonance imaging in the evaluation of systemic amyloidosis. Magn Reson Insights 2019;12:1178623X19843519
- Phelan D, Collier P, Thavendiranathan P, Popovic' ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 2012;98:1442-1448 https://doi.org/10.1136/heartjnl-2012-302353
- Lee GY, Kim HK, Choi JO, Chang SA, Oh JK, Jeon ES, et al. Visual assessment of relative apical sparing pattern is more useful than quantitative assessment for diagnosing cardiac amyloidosis in borderline or mildly increased left ventricular wall thickness. Circ J 2015;79:1575-1584 https://doi.org/10.1253/circj.CJ-14-1328
- Ternacle J, Bodez D, Guellich A, Audureau E, Rappeneau S, Lim P, et al. Causes and causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis. JACC Cardiovasc Imaging 2016;9:126-138 https://doi.org/10.1016/j.jcmg.2015.05.014
- Bandula S, Banypersad SM, Sado D, Flett AS, Punwani S, Taylor SA, et al. Measurement of tissue interstitial volume in healthy patients and those with amyloidosis with equilibrium contrast-enhanced MR imaging. Radiology 2013;268:858-864 https://doi.org/10.1148/radiol.13121889
- Banypersad SM, Fontana M, Maestrini V, Sado DM, Captur G, Petrie A, et al. T1 mapping and survival in systemic lightchain amyloidosis. Eur Heart J 2015;36:244-251 https://doi.org/10.1093/eurheartj/ehu444
- Barros-Gomes S, Williams B, Nhola LF, Grogan M, Maalouf JF, Dispenzieri A, et al. Prognosis of light chain amyloidosis with preserved LVEF: added value of 2D speckle-tracking echocardiography to the current prognostic staging system. JACC Cardiovasc Imaging 2017;10:398-407 https://doi.org/10.1016/j.jcmg.2016.04.008
- Bhatti S, Vallurupalli S, Ambach S, Magier A, Watts E, Truong V, et al. Myocardial strain pattern in patients with cardiac amyloidosis secondary to multiple myeloma: a cardiac MRI feature tracking study. Int J Cardiovasc Imaging 2018;34:27-33 https://doi.org/10.1007/s10554-016-0998-6
- Brooks J, Kramer CM, Salerno M. Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping. J Magn Reson Imaging 2013;38:1591-1595 https://doi.org/10.1002/jmri.24078
- Dungu JN, Valencia O, Pinney JH, Gibbs SD, Rowczenio D, Gilbertson JA, et al. CMR-based differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging 2014;7:133-142 https://doi.org/10.1016/j.jcmg.2013.08.015
- Fontana M, Banypersad SM, Treibel TA, Maestrini V, Sado DM, White SK, et al. Native T1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging 2014;7:157-165 https://doi.org/10.1016/j.jcmg.2013.10.008
- Robbers LF, Baars EN, Brouwer WP, Beek AM, Hofman MB, Niessen HW, et al. T1 mapping shows increased extracellular matrix size in the myocardium due to amyloid depositions. Circ Cardiovasc Imaging 2012;5:423-426 https://doi.org/10.1161/CIRCIMAGING.112.973438
- Dungu JN, Anderson LJ, Whelan CJ, Hawkins PN. Cardiac transthyretin amyloidosis. Heart 2012;98:1546-1554 https://doi.org/10.1136/heartjnl-2012-301924
- Schuster A, Morton G, Hussain ST, Jogiya R, Kutty S, Asrress KN, et al. The intra-observer reproducibility of cardiovascular magnetic resonance myocardial feature tracking strain assessment is independent of field strength. Eur J Radiol 2013;82:296-301 https://doi.org/10.1016/j.ejrad.2012.11.012
- Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 2005;79:319-328 https://doi.org/10.1002/ajh.20381
- The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels, 9th ed. Boston, Mass: Little, Brown & Co, 1994
- Boynton SJ, Geske JB, Dispenzieri A, Syed IS, Hanson TJ, Grogan M, et al. LGE provides incremental prognostic information over serum biomarkers in AL cardiac amyloidosis. JACC Cardiovasc Imaging 2016;9:680-686 https://doi.org/10.1016/j.jcmg.2015.10.027
- Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28:1-39.e14 https://doi.org/10.1016/j.echo.2014.10.003
- Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2016;17:1321-1360 https://doi.org/10.1093/ehjci/jew082
- Dong Y, Yang D, Han Y, Cheng W, Sun J, Wan K, et al. Age and gender impact the measurement of myocardial interstitial fibrosis in a healthy adult Chinese population: a cardiac magnetic resonance study. Front Physiol 2018;9:140
- Falk RH, Skinner M. The systemic amyloidoses: an overview. Adv Intern Med 2000;45:107-137
- Hachulla E, Grateau G. Diagnostic tools for amyloidosis. Joint Bone Spine 2002;69:538-545 https://doi.org/10.1016/S1297-319X(02)00449-9
- vanden Driesen RI, Slaughter RE, Strugnell WE. MR findings in cardiac amyloidosis. AJR Am J Roentgenol 2006;186:1682-1685 https://doi.org/10.2214/AJR.04.0871
- Kramer CM. Role of cardiac MR imaging in cardiomyopathies. J Nucl Med 2015;56 Suppl 4:39S-45S https://doi.org/10.2967/jnumed.114.142729
- Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 2013;6:488-497 https://doi.org/10.1016/j.jcmg.2012.11.013
- Kim PK, Hong YJ, Im DJ, Suh YJ, Park CH, Kim JY, et al. Myocardial T1 and T2 mapping: techniques and clinical applications. Korean J Radiol 2017;18:113-131 https://doi.org/10.3348/kjr.2017.18.1.113
- Fontana M, Banypersad SM, Treibel TA, Maestrini V, Sado D, White SK, et al. AL and ATTR cardiac amyloid are different: native T1 mapping and ECV detect different biology. J Cardiovasc Magn Reson 2014;16:341
- Bravo PE, Fujikura K, Kijewski MF, Jerosch-Herold M, Jacob S, El-Sady MS, et al. Relative apical sparing of myocardial longitudinal strain is explained by regional differences in total amyloid mass rather than the proportion of amyloid deposits. JACC Cardiovasc Imaging 2019;12:1165-1173 https://doi.org/10.1016/j.jcmg.2018.06.016
- Sperry BW, Vranian MN, Tower-Rader A, Hachamovitch R, Hanna M, Brunken R, et al. Regional variation in technetium pyrophosphate uptake in transthyretin cardiac amyloidosis and impact on mortality. JACC Cardiovasc Imaging 2018;11:234-242 https://doi.org/10.1016/j.jcmg.2017.06.020
- Pandey T, Alapati S, Wadhwa V, Edupuganti MM, Gurram P, Lensing S, et al. Evaluation of myocardial strain in patients with amyloidosis using cardiac magnetic resonance feature tracking. Curr Probl Diagn Radiol 2017;46:288-294 https://doi.org/10.1067/j.cpradiol.2016.11.008